614 related articles for article (PubMed ID: 29551551)
1. Correlates of specialty substance use treatment among adults with opioid use disorders.
Romo E; Ulbricht CM; Clark RE; Lapane KL
Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
[TBL] [Abstract][Full Text] [Related]
2. Adults who misuse opioids: Substance abuse treatment use and perceived treatment need.
Choi NG; DiNitto DM; Marti CN; Choi BY
Subst Abus; 2019; 40(2):247-255. PubMed ID: 30810503
[No Abstract] [Full Text] [Related]
3. Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration.
Lin LA; Bohnert ASB; Blow FC; Gordon AJ; Ignacio RV; Kim HM; Ilgen MA
Addiction; 2021 Jan; 116(1):96-104. PubMed ID: 32428386
[TBL] [Abstract][Full Text] [Related]
4. Health, Polysubstance Use, and Criminal Justice Involvement Among Adults With Varying Levels of Opioid Use.
Winkelman TNA; Chang VW; Binswanger IA
JAMA Netw Open; 2018 Jul; 1(3):e180558. PubMed ID: 30646016
[TBL] [Abstract][Full Text] [Related]
5. Use of Medication for Opioid Use Disorder Among US Adolescents and Adults With Need for Opioid Treatment, 2019.
Mauro PM; Gutkind S; Annunziato EM; Samples H
JAMA Netw Open; 2022 Mar; 5(3):e223821. PubMed ID: 35319762
[TBL] [Abstract][Full Text] [Related]
6. Substance abuse treatment and receipt of liver specialty care among persons coinfected with HIV/HCV who have alcohol problems.
Palepu A; Cheng DM; Kim T; Nunes D; Vidaver J; Alperen J; Saitz R; Samet JH
J Subst Abuse Treat; 2006 Dec; 31(4):411-7. PubMed ID: 17084795
[TBL] [Abstract][Full Text] [Related]
7. Age related medication for addiction treatment (MAT) use for opioid use disorder among Medicaid-insured patients in New York.
Neighbors CJ; Choi S; Healy S; Yerneni R; Sun T; Shapoval L
Subst Abuse Treat Prev Policy; 2019 Jun; 14(1):28. PubMed ID: 31238952
[TBL] [Abstract][Full Text] [Related]
8. Correlates of Opioid Use Disorders among People with Severe Mental Illness in the United States.
Prince JD
Subst Use Misuse; 2019; 54(6):1024-1034. PubMed ID: 30658543
[TBL] [Abstract][Full Text] [Related]
9. Co-occurring substance use and mental disorders among adults with opioid use disorder.
Jones CM; McCance-Katz EF
Drug Alcohol Depend; 2019 Apr; 197():78-82. PubMed ID: 30784952
[TBL] [Abstract][Full Text] [Related]
10. Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
Rogal S; Youk A; Agbalajobi O; Zhang H; Gellad W; Fine MJ; Belperio P; Morgan T; Good CB; Kraemer K
Am J Gastroenterol; 2021 Jul; 116(7):1406-1413. PubMed ID: 33811202
[TBL] [Abstract][Full Text] [Related]
11. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates.
Becker WC; Sullivan LE; Tetrault JM; Desai RA; Fiellin DA
Drug Alcohol Depend; 2008 Apr; 94(1-3):38-47. PubMed ID: 18063321
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of US Counties With High Opioid Overdose Mortality and Low Capacity to Deliver Medications for Opioid Use Disorder.
Haffajee RL; Lin LA; Bohnert ASB; Goldstick JE
JAMA Netw Open; 2019 Jun; 2(6):e196373. PubMed ID: 31251376
[TBL] [Abstract][Full Text] [Related]
13. Maternal and infant characteristics associated with maternal opioid overdose in the year following delivery.
Nielsen T; Bernson D; Terplan M; Wakeman SE; Yule AM; Mehta PK; Bharel M; Diop H; Taveras EM; Wilens TE; Schiff DM
Addiction; 2020 Feb; 115(2):291-301. PubMed ID: 31692133
[TBL] [Abstract][Full Text] [Related]
14. Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems.
Campbell CI; Weisner C; Binswanger IA; Lapham GT; Ahmedani BK; Yarborough BJH; Haller IV; Altschuler A; Hechter RC; Loree AM; Kline-Simon AH
Subst Abus; 2019; 40(3):328-334. PubMed ID: 30676931
[No Abstract] [Full Text] [Related]
15. Effectiveness of treatment for opioid use disorder: A national, five-year, prospective, observational study in England.
Eastwood B; Strang J; Marsden J
Drug Alcohol Depend; 2017 Jul; 176():139-147. PubMed ID: 28535456
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive multivariate model of biopsychosocial factors associated with opioid misuse and use disorder in a 2017-2018 United States national survey.
Montiel Ishino FA; McNab PR; Gilreath T; Salmeron B; Williams F
BMC Public Health; 2020 Nov; 20(1):1740. PubMed ID: 33208132
[TBL] [Abstract][Full Text] [Related]
17. Age of initiation, psychopathology, and other substance use are associated with time to use disorder diagnosis in persons using opioids nonmedically.
Schepis TS; Hakes JK
Subst Abus; 2017; 38(4):407-413. PubMed ID: 28723266
[TBL] [Abstract][Full Text] [Related]
18. Trends in and Characteristics of Buprenorphine Misuse Among Adults in the US.
Han B; Jones CM; Einstein EB; Compton WM
JAMA Netw Open; 2021 Oct; 4(10):e2129409. PubMed ID: 34652446
[TBL] [Abstract][Full Text] [Related]
19. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
20. Trends and correlates of driving under the influence of alcohol among different types of adult substance users in the United States: a national survey study.
Park JY; Wu LT
BMC Public Health; 2019 May; 19(1):509. PubMed ID: 31054563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
